Doxazosin Tablet
Product Images NDC 68071-4272

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68071-4272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4272 3

Doxazosin 1 mg tablets packaging label from NuCare Pharmaceuticals, Inc. The label states the product contains 30 tablets with each tablet containing Doxazosin Mesylate USP equivalent to 1 mg Doxazosin. The tablets are described as round, white/off-white, scored, and debossed with 'C3' on the un-scored side. The label includes storage instructions and warnings, the NDC 68071-4272-3, and manufacturer information for NuCare Pharmaceuticals, Inc.*

FDA Label Image

Table 1 (Doxazosin Fig1)

A data table titled 'Summary of Effectiveness Data in Placebo Controlled Trials' presenting symptom scores and maximum flow rate changes for Doxazosin versus placebo in three titration studies. The table includes baseline means, mean changes, and number of subjects across 1 mg, 4 mg, and 8 mg doses. Accompanying the table is a bar graph illustrating maximum flow rate and symptom score changes for placebo, 4 mg, and 8 mg Doxazosin doses, showing dose-dependent improvements.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Two line graphs depicting clinical data for Doxazosin versus placebo over a 14-week treatment period. The first graph shows the mean change in total symptom score from baseline, with Doxazosin demonstrating a greater decrease compared to placebo. The second graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline, where Doxazosin yields higher increases than placebo. Both graphs include sample sizes (N=50 for Doxazosin, N=47 for placebo) and statistical significance markers.*

FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical structure of doxazosin, the active ingredient in the product Doxazosin 1 mg oral tablet by NuCare Pharmaceuticals, Inc. The diagram presents the molecular framework including aromatic rings, nitrogen atoms, and functional groups consistent with doxazosin mesylate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.